Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Journal:
Current Drug Targets
Volume:
6
Page:
301-323
Author(s):
M. Caraglia, A. Budillon, P. Tagliaferri, M. Marra, A. Abbruzzese and F. Caponigro
Drugging Cell Cycle Kinases in Cancer Therapy
Journal:
Current Drug Targets
Volume:
6
Page:
325-335
Author(s):
S. Blagden and J. de Bono
Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase
Journal:
Current Drug Targets
Volume:
6
Page:
337-351
Author(s):
A. Budillon, F. Bruzzese, E. Di Gennaro and M. Caraglia
Recent Developments in the Chemical Biology of Epothilones
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1595-1613
Author(s):
Karl Heinz Altmann
Improving the Targeting of Tubulin-Binding Agents: Lessons from Drug Resistance Studies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1719-1733
Author(s):
N. M. Verrills and M. Kavallaris
Small Molecules and Future Regenerative Medicine
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
383-395
Author(s):
Sheng Ding and Peter G. Schultz
Prospects for Plant-Derived Chemopreventive Agents Exhibiting Multiple Mechanisms of Action
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
201-213
Author(s):
L. M. Howells and M. M. Manson
Cisplatin Is a DNA-Damaging Antitumour Compound Triggering Multifactorial Biochemical Responses in Cancer Cells: Importance of Apoptotic Pathways
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
251-265
Author(s):
Yuliya Sedletska, Marie-Josephe Giraud-Panis and Jean-Marc Malinge
Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
267-279
Author(s):
Nial J. Wheate and J. Grant Collins
Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
281-301
Author(s):
Wenfang Xu and Qianbin Li